Reduced status of plasma total antioxidant capacity in schizophrenia with tardive dyskinesia

Journal of Psychiatric Research

Volumn 44, Issue 15, 2010, Pages 1111-1112

  Chen, Da Chun ^a,c   Xiu, Mei Hong ^a   Liu, Hong ^b   Zhang, Ben Shu ^b   Wang, Yu ^b   Kosten, Thomas R ^c   Zhang, Xiang Yang ^a  

^a BEIJING HUILONGGUAN HOSPITAL   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CATALASE; CHLORPROMAZINE; FREE RADICAL; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NEUROLEPTIC AGENT; SUPEROXIDE DISMUTASE;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LETTER; MALE; OXIDATIVE STRESS; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

EID: 77958152929     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2010.03.008     Document Type: Letter

References (11)

1. Lohr J.B. Oxygen radicals and neuropsychiatric illness. Some speculations. Arch Gen Psychiatry 1991, 48:1097-1106.
2. Lohr J.B., Browning J.A. Free radical involvement in neuropsychiatric illnesses. Psychopharmacol Bull 1995, 31:159-165.
3. Lohr J.B., Kuczenski R., Niculescu A.B. Oxidative mechanisms and tardive dyskinesia. CNS Drugs 2003, 17:47-62.
4. Naidu P.S., Singh A., Kaur P., Sandhir R., Kulkarni S.K. Possible mechanism of action in melatonin attenuation of haloperidol-induced orofacial dyskinesia. Pharmacol Biochem Behav 2003, 74:641-648.
5. Reddy R., Keshavan M., Yao J.K. Reduced plasma antioxidants in first-episode patients with schizophrenia. Schizophr Res 2003, 62:205-212.
6. Schooler N.R., Kane J.M. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 1982, 39:486-487.
7. Yao J.K., Reddy R., McElhinny L.G., van Kammen D.P. Reduced status of plasma total antioxidant capacity in schizophrenia. Schizophr Res 1998, 32:1-8.
8. Yao J.K., Reddy R., van Kammen D.P. Abnormal age-related changes of plasma antioxidant proteins in schizophrenia. Psychiatry Res 2000, 97:137-151.
9. Yao J.K., Reddy R.D., van Kammen D.P. Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 2001, 15:287-310.
10. Zhang X.Y., Zhou D.F., Cao L.Y., Chen D.C., Zhu F.Y., Wu G.Y. Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements. Schizophr Res 2003, 62:245-250.
11. Zhang X.Y., Tan Y.L., Zhou D.F., Cao L.Y., Wu G.Y., Haile C.N., Kosten T.A., Kosten T.R. Disrupted antioxidant enzyme activity and elevated lipid peroxidation products in schizophrenic patients with tardive dyskinesia. J Clin Psychiatry 2007, 68:754-760.